Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Corcept Therapeutics (CORT) Return on Assets (2016 - 2025)

Historic Return on Assets for Corcept Therapeutics (CORT) over the last 13 years, with Q3 2025 value amounting to 0.13%.

  • Corcept Therapeutics' Return on Assets fell 600.0% to 0.13% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.13%, marking a year-over-year decrease of 600.0%. This contributed to the annual value of 0.19% for FY2024, which is 200.0% up from last year.
  • Corcept Therapeutics' Return on Assets amounted to 0.13% in Q3 2025, which was down 600.0% from 0.16% recorded in Q2 2025.
  • In the past 5 years, Corcept Therapeutics' Return on Assets ranged from a high of 0.25% in Q1 2022 and a low of 0.13% during Q3 2025
  • Its 5-year average for Return on Assets is 0.18%, with a median of 0.18% in 2021.
  • Its Return on Assets has fluctuated over the past 5 years, first surged by 700bps in 2022, then tumbled by -900bps in 2023.
  • Quarter analysis of 5 years shows Corcept Therapeutics' Return on Assets stood at 0.22% in 2021, then fell by -19bps to 0.18% in 2022, then fell by -4bps to 0.17% in 2023, then fell by 0bps to 0.17% in 2024, then decreased by -25bps to 0.13% in 2025.
  • Its Return on Assets stands at 0.13% for Q3 2025, versus 0.16% for Q2 2025 and 0.16% for Q1 2025.